Practice question

Answer the question and get instant feedback.

MediumEndocrinologyT2DM therapy optimisationukmlamrcgp aktpanemrcp part 1prescribing safety assessment

A 63-year-old with type 2 diabetes and BMI 35 kg/m² has inadequate glycaemic control on metformin and SGLT2 inhibitor. Established CVD present. Next escalation prioritising weight and CV benefit?

Practice more on iatroX

Educational content. Not a substitute for clinical judgement or local policy.